Literature DB >> 25323615

In hormone-naive metastatic prostate cancer, should all patients now receive docetaxel? No, not yet.

Andrew J Armstrong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25323615

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN： 0890-9091            Impact factor:   2.990


× No keyword cloud information.
  1 in total

1.  Serum testosterone level predicts the effective time of androgen deprivation therapy in metastatic prostate cancer patients.

Authors:  Yue Wang; Bo Dai; Ding-Wei Ye
Journal:  Asian J Androl       Date:  2017 Mar-Apr       Impact factor: 3.285
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.